The Cyclin D1 (CCND1) A870G polymorphism predicts clinical outcome to lapatinib and capecitabine in HER2-positive metastatic breast cancer
LaBonte, M. J., Wilson, P. M., Yang, D., Zhang, W., Ladner, R. D., Ning, Y., Gerger, A., Bohanes, P. O., Benhaim, L., El-khoueiry, R., El-khoueiry, A., Lenz, H.- J.Volume:
23
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdr445
Date:
June, 2012
File:
PDF, 481 KB
english, 2012